AUTHOREA
Log in Sign Up Browse Preprints
LOG IN SIGN UP
Yingying Zhang
Yingying Zhang

Public Documents 1
July 26, 2022
The combination of omalizumab improves the safety and efficacy of allergen immunother...
Yingying Zhang

| Powered by Authorea.com

  • Home